{"SLR NAME":"Prevalence and impact of cardiac injury in patients with COVID-19","References":[{"title1":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title2":"The novel coronavirus originating in Wuhan, China: challenges for global health governance","References":[]},{"title2":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group","References":[]},{"title2":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)","References":[]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"}]},{"title2":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society","References":[]},{"title2":"KDIGO clinical practice guidelines for acute kidney injury","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin Definition","References":[]},{"title2":"Chinese management guideline for COVID-19 (version 6.0)","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"}]},{"title2":"Middle East respiratory syndrome","References":[]},{"title2":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong","References":[]},{"title2":"Predictors of mortality in Middle East respiratory syndrome (MERS)","References":[{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"}]},{"title2":"Exacerbated innate host response to SARS-CoV in aged non-human primates","References":[{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"}]},{"title2":"The immunopathogenesis of sepsis in elderly patients","References":[]},{"title2":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","References":[{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"}]},{"title2":"Serial evaluation of the SOFA score to predict outcome in critically ill patients","References":[]},{"title2":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network","References":[]},{"title2":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study","References":[]},{"title2":"Acute pneumonia and the cardiovascular system","References":[]},{"title2":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis","References":[]},{"title2":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015","References":[{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"}]},{"title2":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia","References":[]},{"title2":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis","References":[]},{"title2":"Risk of myocardial infarction and stroke after acute infection or vaccination","References":[]},{"title2":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality","References":[]},{"title2":"Cardiovascular complications of acute respiratory infections: current research and future directions","References":[]},{"title2":"Regulation of ACE2 in cardiac myocytes and fibroblasts","References":[]},{"title2":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension","References":[]},{"title2":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","References":[{"title3":"Pathological%20findings%20of%20COVID-19%20associated%20with%20acute%20respiratory%20distress%20syndrome"},{"title3":"Pathological%20findings%20of%20COVID-19%20associated%20with%20acute%20respiratory%20distress%20syndrome"},{"title3":"Pathological%20findings%20of%20COVID-19%20associated%20with%20acute%20respiratory%20distress%20syndrome"},{"title3":"Pathological%20findings%20of%20COVID-19%20associated%20with%20acute%20respiratory%20distress%20syndrome"},{"title3":"Pathological%20findings%20of%20COVID-19%20associated%20with%20acute%20respiratory%20distress%20syndrome"}]},{"title2":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase","References":[{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"}]},{"title2":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection","References":[]},{"title2":"Viral load kinetics of MERS coronavirus infection","References":[]},{"title2":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection","References":[{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"}]},{"title2":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","References":[{"title3":"SARS-CoV-2%20viral%20load%20in%20upper%20respiratory%20specimens%20of%20infected%20patients"},{"title3":"SARS-CoV-2%20viral%20load%20in%20upper%20respiratory%20specimens%20of%20infected%20patients"},{"title3":"SARS-CoV-2%20viral%20load%20in%20upper%20respiratory%20specimens%20of%20infected%20patients"},{"title3":"SARS-CoV-2%20viral%20load%20in%20upper%20respiratory%20specimens%20of%20infected%20patients"},{"title3":"SARS-CoV-2%20viral%20load%20in%20upper%20respiratory%20specimens%20of%20infected%20patients"}]}]},{"title1":"Clinical Features and Outcomes of 98 Patients Hospitalized with SARS-CoV-2 Infection in Daegu, South Korea: A Brief Descriptive Study","References":[{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirusinfected pneumonia in Wuhan, China","References":[]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"}]},{"title2":"The ability of the National Early Warning Score (NEWS) to discriminate patients at risk of early cardiac arrest, unanticipated intensive care unit admission, and death","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin Definition","References":[]},{"title2":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","References":[{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"},{"title3":"The%20third%20international%20consensus%20definitions%20for%20sepsis%20and%20septic%20shock%20(Sepsis-3)"}]},{"title2":"KDIGO clinical practice guidelines for acute kidney injury","References":[]},{"title2":"APACHE II: a severity of disease classification system","References":[]},{"title2":"Accuracy and reliability of APACHE II scoring in two intensive care units problems and pitfalls in the use of APACHE II and suggestions for improvement","References":[]},{"title2":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine","References":[]},{"title2":"Report on the epidemiological features of coronavirus disease 2019 (COVID-19) outbreak in the Republic of Korea from January 19 to March 2, 2020","References":[{"title3":"Report%20on%20the%20epidemiological%20features%20of%20coronavirus%20disease%202019%20(COVID-19)%20outbreak%20in%20the%20Republic%20of%20Korea%20from%20January%2019%20to%20March%202,%202020"},{"title3":"Report%20on%20the%20epidemiological%20features%20of%20coronavirus%20disease%202019%20(COVID-19)%20outbreak%20in%20the%20Republic%20of%20Korea%20from%20January%2019%20to%20March%202,%202020"},{"title3":"Report%20on%20the%20epidemiological%20features%20of%20coronavirus%20disease%202019%20(COVID-19)%20outbreak%20in%20the%20Republic%20of%20Korea%20from%20January%2019%20to%20March%202,%202020"},{"title3":"Report%20on%20the%20epidemiological%20features%20of%20coronavirus%20disease%202019%20(COVID-19)%20outbreak%20in%20the%20Republic%20of%20Korea%20from%20January%2019%20to%20March%202,%202020"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"}]},{"title2":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","References":[]},{"title2":"Clinical progression and cytokine profiles of middle east respiratory syndrome coronavirus infection","References":[{"title3":"Clinical%20progression%20and%20cytokine%20profiles%20of%20middle%20east%20respiratory%20syndrome%20coronavirus%20infection"},{"title3":"Clinical%20progression%20and%20cytokine%20profiles%20of%20middle%20east%20respiratory%20syndrome%20coronavirus%20infection"},{"title3":"Clinical%20progression%20and%20cytokine%20profiles%20of%20middle%20east%20respiratory%20syndrome%20coronavirus%20infection"},{"title3":"Clinical%20progression%20and%20cytokine%20profiles%20of%20middle%20east%20respiratory%20syndrome%20coronavirus%20infection"},{"title3":"Clinical%20progression%20and%20cytokine%20profiles%20of%20middle%20east%20respiratory%20syndrome%20coronavirus%20infection"},{"title3":"Clinical%20progression%20and%20cytokine%20profiles%20of%20middle%20east%20respiratory%20syndrome%20coronavirus%20infection"},{"title3":"Clinical%20progression%20and%20cytokine%20profiles%20of%20middle%20east%20respiratory%20syndrome%20coronavirus%20infection"},{"title3":"Clinical%20progression%20and%20cytokine%20profiles%20of%20middle%20east%20respiratory%20syndrome%20coronavirus%20infection"},{"title3":"Clinical%20progression%20and%20cytokine%20profiles%20of%20middle%20east%20respiratory%20syndrome%20coronavirus%20infection"},{"title3":"Clinical%20progression%20and%20cytokine%20profiles%20of%20middle%20east%20respiratory%20syndrome%20coronavirus%20infection"},{"title3":"Clinical%20progression%20and%20cytokine%20profiles%20of%20middle%20east%20respiratory%20syndrome%20coronavirus%20infection"},{"title3":"Clinical%20progression%20and%20cytokine%20profiles%20of%20middle%20east%20respiratory%20syndrome%20coronavirus%20infection"},{"title3":"Clinical%20progression%20and%20cytokine%20profiles%20of%20middle%20east%20respiratory%20syndrome%20coronavirus%20infection"},{"title3":"Clinical%20progression%20and%20cytokine%20profiles%20of%20middle%20east%20respiratory%20syndrome%20coronavirus%20infection"},{"title3":"Clinical%20progression%20and%20cytokine%20profiles%20of%20middle%20east%20respiratory%20syndrome%20coronavirus%20infection"},{"title3":"Clinical%20progression%20and%20cytokine%20profiles%20of%20middle%20east%20respiratory%20syndrome%20coronavirus%20infection"},{"title3":"Clinical%20progression%20and%20cytokine%20profiles%20of%20middle%20east%20respiratory%20syndrome%20coronavirus%20infection"},{"title3":"Clinical%20progression%20and%20cytokine%20profiles%20of%20middle%20east%20respiratory%20syndrome%20coronavirus%20infection"},{"title3":"Clinical%20progression%20and%20cytokine%20profiles%20of%20middle%20east%20respiratory%20syndrome%20coronavirus%20infection"},{"title3":"Clinical%20progression%20and%20cytokine%20profiles%20of%20middle%20east%20respiratory%20syndrome%20coronavirus%20infection"},{"title3":"Clinical%20progression%20and%20cytokine%20profiles%20of%20middle%20east%20respiratory%20syndrome%20coronavirus%20infection"},{"title3":"Clinical%20progression%20and%20cytokine%20profiles%20of%20middle%20east%20respiratory%20syndrome%20coronavirus%20infection"},{"title3":"Clinical%20progression%20and%20cytokine%20profiles%20of%20middle%20east%20respiratory%20syndrome%20coronavirus%20infection"}]},{"title2":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","References":[{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"}]}]},{"title1":"Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study","References":[{"title2":"Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020. 10.1002/jmv.25678.","References":[]},{"title2":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China","References":[{"title3":"The%20continuing%202019-nCoV%20epidemic%20threat%20of%20novel%20coronaviruses%20to%20global%20health%20-%20the%20latest%202019%20novel%20coronavirus%20outbreak%20in%20Wuhan,%20China"},{"title3":"The%20continuing%202019-nCoV%20epidemic%20threat%20of%20novel%20coronaviruses%20to%20global%20health%20-%20the%20latest%202019%20novel%20coronavirus%20outbreak%20in%20Wuhan,%20China"},{"title3":"The%20continuing%202019-nCoV%20epidemic%20threat%20of%20novel%20coronaviruses%20to%20global%20health%20-%20the%20latest%202019%20novel%20coronavirus%20outbreak%20in%20Wuhan,%20China"},{"title3":"The%20continuing%202019-nCoV%20epidemic%20threat%20of%20novel%20coronaviruses%20to%20global%20health%20-%20the%20latest%202019%20novel%20coronavirus%20outbreak%20in%20Wuhan,%20China"},{"title3":"The%20continuing%202019-nCoV%20epidemic%20threat%20of%20novel%20coronaviruses%20to%20global%20health%20-%20the%20latest%202019%20novel%20coronavirus%20outbreak%20in%20Wuhan,%20China"}]},{"title2":"Paules CI, Marston HD, Fauci AS. Coronavirus infections-more than just the common cold. JAMA. 2020. 10.1001/jama.2020.0757.","References":[]},{"title2":"WHO. Situation report-55. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200315-sitrep-55-covid-19.pdf?sfvrsn=33daa5cb_6. Accessed 12 Apr 2020.","References":[]},{"title2":"WHO: Shortage of personal protective equipment endangering health workers worldwide. https://www.who.int/news-room/detail/03-03-2020-shortage-of-personal-protective-equipment-endangering-health-workers-worldwide. Accessed 12 Apr 2020.","References":[]},{"title2":"Ji Y, Ma Z, Peppelenbosch MP, Pan Q. Potential association between COVID-19 mortality and health-care resource availability. Lancet Glob Health. 2020. 10.1016/S2214-109X(20)30068-1.","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"}]},{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"}]},{"title2":"Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020. 10.1016/S2213-2600(20)30079-5.","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin definition","References":[]},{"title2":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","References":[{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"}]},{"title2":"KDIGO clinical practice guidelines for acute kidney injury","References":[]},{"title2":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020. 10.1001/jama.2020.2648.","References":[]},{"title2":"National Health Commission of the People's Republic of China. Feb 27: daily briefing on novel coronavirus cases in China. http://en.nhc.gov.cn/2020-02/27/c_76975.htm. Accessed 12 Apr 2020.","References":[]},{"title2":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS, China Medical Treatment Expert Group for C. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020. 10.1056/NEJMoa2002032.","References":[]},{"title2":"Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort study","References":[]},{"title2":"Lessons to learn from epidemiologic studies in ARDS","References":[]},{"title2":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020. 10.1001/jama.2020.1585.","References":[]},{"title2":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study","References":[]},{"title2":"Persistent lymphopenia is a risk factor for ICU-acquired infections and for death in ICU patients with sustained hypotension at admission","References":[{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"},{"title3":"Persistent%20lymphopenia%20is%20a%20risk%20factor%20for%20ICU-acquired%20infections%20and%20for%20death%20in%20ICU%20patients%20with%20sustained%20hypotension%20at%20admission"}]},{"title2":"Association of lymphopenia with short term outcomes of sepsis patients; a brief report","References":[{"title3":"Association%20of%20lymphopenia%20with%20short%20term%20outcomes%20of%20sepsis%20patients;%20a%20brief%20report"},{"title3":"Association%20of%20lymphopenia%20with%20short%20term%20outcomes%20of%20sepsis%20patients;%20a%20brief%20report"},{"title3":"Association%20of%20lymphopenia%20with%20short%20term%20outcomes%20of%20sepsis%20patients;%20a%20brief%20report"},{"title3":"Association%20of%20lymphopenia%20with%20short%20term%20outcomes%20of%20sepsis%20patients;%20a%20brief%20report"},{"title3":"Association%20of%20lymphopenia%20with%20short%20term%20outcomes%20of%20sepsis%20patients;%20a%20brief%20report"},{"title3":"Association%20of%20lymphopenia%20with%20short%20term%20outcomes%20of%20sepsis%20patients;%20a%20brief%20report"},{"title3":"Association%20of%20lymphopenia%20with%20short%20term%20outcomes%20of%20sepsis%20patients;%20a%20brief%20report"},{"title3":"Association%20of%20lymphopenia%20with%20short%20term%20outcomes%20of%20sepsis%20patients;%20a%20brief%20report"},{"title3":"Association%20of%20lymphopenia%20with%20short%20term%20outcomes%20of%20sepsis%20patients;%20a%20brief%20report"},{"title3":"Association%20of%20lymphopenia%20with%20short%20term%20outcomes%20of%20sepsis%20patients;%20a%20brief%20report"},{"title3":"Association%20of%20lymphopenia%20with%20short%20term%20outcomes%20of%20sepsis%20patients;%20a%20brief%20report"},{"title3":"Association%20of%20lymphopenia%20with%20short%20term%20outcomes%20of%20sepsis%20patients;%20a%20brief%20report"},{"title3":"Association%20of%20lymphopenia%20with%20short%20term%20outcomes%20of%20sepsis%20patients;%20a%20brief%20report"},{"title3":"Association%20of%20lymphopenia%20with%20short%20term%20outcomes%20of%20sepsis%20patients;%20a%20brief%20report"},{"title3":"Association%20of%20lymphopenia%20with%20short%20term%20outcomes%20of%20sepsis%20patients;%20a%20brief%20report"},{"title3":"Association%20of%20lymphopenia%20with%20short%20term%20outcomes%20of%20sepsis%20patients;%20a%20brief%20report"}]},{"title2":"Li Z, Wu M, Guo J, Yao J, Liao X, Song S, Han M, Li J, Duan G, Zhou Y, Wu X, Zhou Z, Wang T, Hu M, Chen X, Fu Y, Lei C, Dong H, Zhou Y, Jia H, Chen X, Yan J (2020) Caution on kidney dysfunctions of 2019-nCoV patients. medRxiv:2020.2002.2008.20021212. doi:10.1101/2020.02.08.20021212.","References":[]},{"title2":"Critically ill patients with severe acute respiratory syndrome","References":[{"title3":"Critically%20ill%20patients%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"Critically%20ill%20patients%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"Critically%20ill%20patients%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"Critically%20ill%20patients%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"Critically%20ill%20patients%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"Critically%20ill%20patients%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"Critically%20ill%20patients%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"Critically%20ill%20patients%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"Critically%20ill%20patients%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"Critically%20ill%20patients%20with%20severe%20acute%20respiratory%20syndrome"},{"title3":"Critically%20ill%20patients%20with%20severe%20acute%20respiratory%20syndrome"}]},{"title2":"Chest radiography versus lung ultrasound for identification of acute respiratory distress syndrome: a retrospective observational study","References":[{"title3":"Chest%20radiography%20versus%20lung%20ultrasound%20for%20identification%20of%20acute%20respiratory%20distress%20syndrome:%20a%20retrospective%20observational%20study"},{"title3":"Chest%20radiography%20versus%20lung%20ultrasound%20for%20identification%20of%20acute%20respiratory%20distress%20syndrome:%20a%20retrospective%20observational%20study"},{"title3":"Chest%20radiography%20versus%20lung%20ultrasound%20for%20identification%20of%20acute%20respiratory%20distress%20syndrome:%20a%20retrospective%20observational%20study"},{"title3":"Chest%20radiography%20versus%20lung%20ultrasound%20for%20identification%20of%20acute%20respiratory%20distress%20syndrome:%20a%20retrospective%20observational%20study"},{"title3":"Chest%20radiography%20versus%20lung%20ultrasound%20for%20identification%20of%20acute%20respiratory%20distress%20syndrome:%20a%20retrospective%20observational%20study"},{"title3":"Chest%20radiography%20versus%20lung%20ultrasound%20for%20identification%20of%20acute%20respiratory%20distress%20syndrome:%20a%20retrospective%20observational%20study"},{"title3":"Chest%20radiography%20versus%20lung%20ultrasound%20for%20identification%20of%20acute%20respiratory%20distress%20syndrome:%20a%20retrospective%20observational%20study"},{"title3":"Chest%20radiography%20versus%20lung%20ultrasound%20for%20identification%20of%20acute%20respiratory%20distress%20syndrome:%20a%20retrospective%20observational%20study"},{"title3":"Chest%20radiography%20versus%20lung%20ultrasound%20for%20identification%20of%20acute%20respiratory%20distress%20syndrome:%20a%20retrospective%20observational%20study"},{"title3":"Chest%20radiography%20versus%20lung%20ultrasound%20for%20identification%20of%20acute%20respiratory%20distress%20syndrome:%20a%20retrospective%20observational%20study"},{"title3":"Chest%20radiography%20versus%20lung%20ultrasound%20for%20identification%20of%20acute%20respiratory%20distress%20syndrome:%20a%20retrospective%20observational%20study"},{"title3":"Chest%20radiography%20versus%20lung%20ultrasound%20for%20identification%20of%20acute%20respiratory%20distress%20syndrome:%20a%20retrospective%20observational%20study"},{"title3":"Chest%20radiography%20versus%20lung%20ultrasound%20for%20identification%20of%20acute%20respiratory%20distress%20syndrome:%20a%20retrospective%20observational%20study"},{"title3":"Chest%20radiography%20versus%20lung%20ultrasound%20for%20identification%20of%20acute%20respiratory%20distress%20syndrome:%20a%20retrospective%20observational%20study"},{"title3":"Chest%20radiography%20versus%20lung%20ultrasound%20for%20identification%20of%20acute%20respiratory%20distress%20syndrome:%20a%20retrospective%20observational%20study"},{"title3":"Chest%20radiography%20versus%20lung%20ultrasound%20for%20identification%20of%20acute%20respiratory%20distress%20syndrome:%20a%20retrospective%20observational%20study"},{"title3":"Chest%20radiography%20versus%20lung%20ultrasound%20for%20identification%20of%20acute%20respiratory%20distress%20syndrome:%20a%20retrospective%20observational%20study"},{"title3":"Chest%20radiography%20versus%20lung%20ultrasound%20for%20identification%20of%20acute%20respiratory%20distress%20syndrome:%20a%20retrospective%20observational%20study"},{"title3":"Chest%20radiography%20versus%20lung%20ultrasound%20for%20identification%20of%20acute%20respiratory%20distress%20syndrome:%20a%20retrospective%20observational%20study"},{"title3":"Chest%20radiography%20versus%20lung%20ultrasound%20for%20identification%20of%20acute%20respiratory%20distress%20syndrome:%20a%20retrospective%20observational%20study"},{"title3":"Chest%20radiography%20versus%20lung%20ultrasound%20for%20identification%20of%20acute%20respiratory%20distress%20syndrome:%20a%20retrospective%20observational%20study"}]},{"title2":"Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Iotti G, Latronico N, Lorini L, Merler S, Natalini G, Piatti A, Ranieri MV, Scandroglio AM, Storti E, Cecconi M, Pesenti A, Network C-LI. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020. 10.1001/jama.2020.5394.","References":[]},{"title2":"Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, Lee M. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state. JAMA. 2020. 10.1001/jama.2020.4326.","References":[]}]},{"title1":"Analysis of 92 deceased patients with COVID?19","References":[{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"}]},{"title2":"  . Home page. http://www.nhc.gov.cn/xcs/yqtb/202004/fa7bb40a7fbf4b2c8f3989d512fe5b77.shtml. Accessed March 10, 2020.","References":[]},{"title2":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","References":[{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"}]},{"title2":"Importation and human-to-human transmission of a novel coronavirus in Vietnam","References":[{"title3":"Importation%20and%20human-to-human%20transmission%20of%20a%20novel%20coronavirus%20in%20Vietnam"},{"title3":"Importation%20and%20human-to-human%20transmission%20of%20a%20novel%20coronavirus%20in%20Vietnam"}]},{"title2":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany","References":[{"title3":"Transmission%20of%202019-nCoV%20infection%20from%20an%20asymptomatic%20contact%20in%20Germany"},{"title3":"Transmission%20of%202019-nCoV%20infection%20from%20an%20asymptomatic%20contact%20in%20Germany"}]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"}]},{"title2":"Guideline for diagnosis and treatment of novel coronavirus-infected pneumonia (Trial version 3)","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin definition","References":[]},{"title2":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China","References":[{"title3":"The%20clinical%20pathology%20of%20severe%20acute%20respiratory%20syndrome%20(SARS):%20a%20report%20from%20China"},{"title3":"The%20clinical%20pathology%20of%20severe%20acute%20respiratory%20syndrome%20(SARS):%20a%20report%20from%20China"},{"title3":"The%20clinical%20pathology%20of%20severe%20acute%20respiratory%20syndrome%20(SARS):%20a%20report%20from%20China"},{"title3":"The%20clinical%20pathology%20of%20severe%20acute%20respiratory%20syndrome%20(SARS):%20a%20report%20from%20China"},{"title3":"The%20clinical%20pathology%20of%20severe%20acute%20respiratory%20syndrome%20(SARS):%20a%20report%20from%20China"},{"title3":"The%20clinical%20pathology%20of%20severe%20acute%20respiratory%20syndrome%20(SARS):%20a%20report%20from%20China"}]},{"title2":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014","References":[{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"},{"title3":"Clinicopathologic,%20immunohistochemical,%20and%20ultrastructural%20findings%20of%20a%20fatal%20case%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20infection%20in%20the%20United%20Arab%20Emirates,%20April%202014"}]},{"title2":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","References":[{"title3":"Pathological%20findings%20of%20COVID-19%20associated%20with%20acute%20respiratory%20distress%20syndrome"},{"title3":"Pathological%20findings%20of%20COVID-19%20associated%20with%20acute%20respiratory%20distress%20syndrome"},{"title3":"Pathological%20findings%20of%20COVID-19%20associated%20with%20acute%20respiratory%20distress%20syndrome"},{"title3":"Pathological%20findings%20of%20COVID-19%20associated%20with%20acute%20respiratory%20distress%20syndrome"},{"title3":"Pathological%20findings%20of%20COVID-19%20associated%20with%20acute%20respiratory%20distress%20syndrome"}]},{"title2":"Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience","References":[]},{"title2":"Cardiovascular complications of severe acute respiratory syndrome","References":[]},{"title2":"CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis","References":[]},{"title2":"Myocarditis","References":[]},{"title2":"Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS)","References":[]},{"title2":"Sepsis, systemic inflammatory response, and multiple organ dysfunction: the mystery continues","References":[]},{"title2":"An interferon-gamma-related cytokine storm in SARS patients","References":[{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"},{"title3":"An%20interferon-gamma-related%20cytokine%20storm%20in%20SARS%20patients"}]},{"title2":"Integrated clinical, pathologic, virologic, and transcriptomic analysis of H5N1 influenza virus-induced viral pneumonia in the rhesus macaque","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"}]},{"title2":"Innate immune signaling and proteolytic pathways in the resolution or exacerbation of SARS-CoV-2 in Covid-19: key therapeutic targets?","References":[{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"},{"title3":"Innate%20immune%20signaling%20and%20proteolytic%20pathways%20in%20the%20resolution%20or%20exacerbation%20of%20SARS-CoV-2%20in%20Covid-19:%20key%20therapeutic%20targets?"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"}]},{"title2":"Urgent avenues in the treatment of COVID-19: targeting downstream inflammation to prevent catastrophic syndrome","References":[{"title3":"Urgent%20avenues%20in%20the%20treatment%20of%20COVID-19:%20targeting%20downstream%20inflammation%20to%20prevent%20catastrophic%20syndrome"},{"title3":"Urgent%20avenues%20in%20the%20treatment%20of%20COVID-19:%20targeting%20downstream%20inflammation%20to%20prevent%20catastrophic%20syndrome"},{"title3":"Urgent%20avenues%20in%20the%20treatment%20of%20COVID-19:%20targeting%20downstream%20inflammation%20to%20prevent%20catastrophic%20syndrome"},{"title3":"Urgent%20avenues%20in%20the%20treatment%20of%20COVID-19:%20targeting%20downstream%20inflammation%20to%20prevent%20catastrophic%20syndrome"},{"title3":"Urgent%20avenues%20in%20the%20treatment%20of%20COVID-19:%20targeting%20downstream%20inflammation%20to%20prevent%20catastrophic%20syndrome"},{"title3":"Urgent%20avenues%20in%20the%20treatment%20of%20COVID-19:%20targeting%20downstream%20inflammation%20to%20prevent%20catastrophic%20syndrome"},{"title3":"Urgent%20avenues%20in%20the%20treatment%20of%20COVID-19:%20targeting%20downstream%20inflammation%20to%20prevent%20catastrophic%20syndrome"},{"title3":"Urgent%20avenues%20in%20the%20treatment%20of%20COVID-19:%20targeting%20downstream%20inflammation%20to%20prevent%20catastrophic%20syndrome"},{"title3":"Urgent%20avenues%20in%20the%20treatment%20of%20COVID-19:%20targeting%20downstream%20inflammation%20to%20prevent%20catastrophic%20syndrome"}]},{"title2":"SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases","References":[{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"},{"title3":"SARS-associated%20viral%20hepatitis%20caused%20by%20a%20novel%20coronavirus:%20report%20of%20three%20cases"}]},{"title2":"Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection-clinicopathological and ultrastructural study","References":[{"title3":"Histopathology%20of%20Middle%20East%20respiratory%20syndrome%20coronovirus%20(MERS-CoV)%20infection-clinicopathological%20and%20ultrastructural%20study"},{"title3":"Histopathology%20of%20Middle%20East%20respiratory%20syndrome%20coronovirus%20(MERS-CoV)%20infection-clinicopathological%20and%20ultrastructural%20study"},{"title3":"Histopathology%20of%20Middle%20East%20respiratory%20syndrome%20coronovirus%20(MERS-CoV)%20infection-clinicopathological%20and%20ultrastructural%20study"},{"title3":"Histopathology%20of%20Middle%20East%20respiratory%20syndrome%20coronovirus%20(MERS-CoV)%20infection-clinicopathological%20and%20ultrastructural%20study"},{"title3":"Histopathology%20of%20Middle%20East%20respiratory%20syndrome%20coronovirus%20(MERS-CoV)%20infection-clinicopathological%20and%20ultrastructural%20study"},{"title3":"Histopathology%20of%20Middle%20East%20respiratory%20syndrome%20coronovirus%20(MERS-CoV)%20infection-clinicopathological%20and%20ultrastructural%20study"},{"title3":"Histopathology%20of%20Middle%20East%20respiratory%20syndrome%20coronovirus%20(MERS-CoV)%20infection-clinicopathological%20and%20ultrastructural%20study"},{"title3":"Histopathology%20of%20Middle%20East%20respiratory%20syndrome%20coronovirus%20(MERS-CoV)%20infection-clinicopathological%20and%20ultrastructural%20study"},{"title3":"Histopathology%20of%20Middle%20East%20respiratory%20syndrome%20coronovirus%20(MERS-CoV)%20infection-clinicopathological%20and%20ultrastructural%20study"},{"title3":"Histopathology%20of%20Middle%20East%20respiratory%20syndrome%20coronovirus%20(MERS-CoV)%20infection-clinicopathological%20and%20ultrastructural%20study"},{"title3":"Histopathology%20of%20Middle%20East%20respiratory%20syndrome%20coronovirus%20(MERS-CoV)%20infection-clinicopathological%20and%20ultrastructural%20study"},{"title3":"Histopathology%20of%20Middle%20East%20respiratory%20syndrome%20coronovirus%20(MERS-CoV)%20infection-clinicopathological%20and%20ultrastructural%20study"},{"title3":"Histopathology%20of%20Middle%20East%20respiratory%20syndrome%20coronovirus%20(MERS-CoV)%20infection-clinicopathological%20and%20ultrastructural%20study"},{"title3":"Histopathology%20of%20Middle%20East%20respiratory%20syndrome%20coronovirus%20(MERS-CoV)%20infection-clinicopathological%20and%20ultrastructural%20study"},{"title3":"Histopathology%20of%20Middle%20East%20respiratory%20syndrome%20coronovirus%20(MERS-CoV)%20infection-clinicopathological%20and%20ultrastructural%20study"},{"title3":"Histopathology%20of%20Middle%20East%20respiratory%20syndrome%20coronovirus%20(MERS-CoV)%20infection-clinicopathological%20and%20ultrastructural%20study"},{"title3":"Histopathology%20of%20Middle%20East%20respiratory%20syndrome%20coronovirus%20(MERS-CoV)%20infection-clinicopathological%20and%20ultrastructural%20study"},{"title3":"Histopathology%20of%20Middle%20East%20respiratory%20syndrome%20coronovirus%20(MERS-CoV)%20infection-clinicopathological%20and%20ultrastructural%20study"}]},{"title2":"Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: a retrospective study","References":[{"title3":"Clinical%20characteristics%20of%20non-ICU%20hospitalized%20patients%20with%20coronavirus%20disease%202019%20and%20liver%20injury:%20a%20retrospective%20study"},{"title3":"Clinical%20characteristics%20of%20non-ICU%20hospitalized%20patients%20with%20coronavirus%20disease%202019%20and%20liver%20injury:%20a%20retrospective%20study"},{"title3":"Clinical%20characteristics%20of%20non-ICU%20hospitalized%20patients%20with%20coronavirus%20disease%202019%20and%20liver%20injury:%20a%20retrospective%20study"},{"title3":"Clinical%20characteristics%20of%20non-ICU%20hospitalized%20patients%20with%20coronavirus%20disease%202019%20and%20liver%20injury:%20a%20retrospective%20study"},{"title3":"Clinical%20characteristics%20of%20non-ICU%20hospitalized%20patients%20with%20coronavirus%20disease%202019%20and%20liver%20injury:%20a%20retrospective%20study"},{"title3":"Clinical%20characteristics%20of%20non-ICU%20hospitalized%20patients%20with%20coronavirus%20disease%202019%20and%20liver%20injury:%20a%20retrospective%20study"},{"title3":"Clinical%20characteristics%20of%20non-ICU%20hospitalized%20patients%20with%20coronavirus%20disease%202019%20and%20liver%20injury:%20a%20retrospective%20study"},{"title3":"Clinical%20characteristics%20of%20non-ICU%20hospitalized%20patients%20with%20coronavirus%20disease%202019%20and%20liver%20injury:%20a%20retrospective%20study"},{"title3":"Clinical%20characteristics%20of%20non-ICU%20hospitalized%20patients%20with%20coronavirus%20disease%202019%20and%20liver%20injury:%20a%20retrospective%20study"},{"title3":"Clinical%20characteristics%20of%20non-ICU%20hospitalized%20patients%20with%20coronavirus%20disease%202019%20and%20liver%20injury:%20a%20retrospective%20study"},{"title3":"Clinical%20characteristics%20of%20non-ICU%20hospitalized%20patients%20with%20coronavirus%20disease%202019%20and%20liver%20injury:%20a%20retrospective%20study"},{"title3":"Clinical%20characteristics%20of%20non-ICU%20hospitalized%20patients%20with%20coronavirus%20disease%202019%20and%20liver%20injury:%20a%20retrospective%20study"}]},{"title2":"Liver injury in COVID-19: management and challenges","References":[{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"},{"title3":"Liver%20injury%20in%20COVID-19:%20management%20and%20challenges"}]},{"title2":"Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection","References":[]},{"title2":"Renal ACE2 expression in human kidney disease","References":[]},{"title2":"ACE2 expression in kidney and testis may cause kidney and testis damage after 2019-nCoV infection","References":[]},{"title2":"Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues","References":[{"title3":"Expression%20of%20the%20SARS-CoV-2%20cell%20receptor%20gene%20ACE2%20in%20a%20wide%20variety%20of%20human%20tissues"},{"title3":"Expression%20of%20the%20SARS-CoV-2%20cell%20receptor%20gene%20ACE2%20in%20a%20wide%20variety%20of%20human%20tissues"},{"title3":"Expression%20of%20the%20SARS-CoV-2%20cell%20receptor%20gene%20ACE2%20in%20a%20wide%20variety%20of%20human%20tissues"},{"title3":"Expression%20of%20the%20SARS-CoV-2%20cell%20receptor%20gene%20ACE2%20in%20a%20wide%20variety%20of%20human%20tissues"},{"title3":"Expression%20of%20the%20SARS-CoV-2%20cell%20receptor%20gene%20ACE2%20in%20a%20wide%20variety%20of%20human%20tissues"},{"title3":"Expression%20of%20the%20SARS-CoV-2%20cell%20receptor%20gene%20ACE2%20in%20a%20wide%20variety%20of%20human%20tissues"},{"title3":"Expression%20of%20the%20SARS-CoV-2%20cell%20receptor%20gene%20ACE2%20in%20a%20wide%20variety%20of%20human%20tissues"},{"title3":"Expression%20of%20the%20SARS-CoV-2%20cell%20receptor%20gene%20ACE2%20in%20a%20wide%20variety%20of%20human%20tissues"},{"title3":"Expression%20of%20the%20SARS-CoV-2%20cell%20receptor%20gene%20ACE2%20in%20a%20wide%20variety%20of%20human%20tissues"},{"title3":"Expression%20of%20the%20SARS-CoV-2%20cell%20receptor%20gene%20ACE2%20in%20a%20wide%20variety%20of%20human%20tissues"},{"title3":"Expression%20of%20the%20SARS-CoV-2%20cell%20receptor%20gene%20ACE2%20in%20a%20wide%20variety%20of%20human%20tissues"},{"title3":"Expression%20of%20the%20SARS-CoV-2%20cell%20receptor%20gene%20ACE2%20in%20a%20wide%20variety%20of%20human%20tissues"},{"title3":"Expression%20of%20the%20SARS-CoV-2%20cell%20receptor%20gene%20ACE2%20in%20a%20wide%20variety%20of%20human%20tissues"},{"title3":"Expression%20of%20the%20SARS-CoV-2%20cell%20receptor%20gene%20ACE2%20in%20a%20wide%20variety%20of%20human%20tissues"},{"title3":"Expression%20of%20the%20SARS-CoV-2%20cell%20receptor%20gene%20ACE2%20in%20a%20wide%20variety%20of%20human%20tissues"},{"title3":"Expression%20of%20the%20SARS-CoV-2%20cell%20receptor%20gene%20ACE2%20in%20a%20wide%20variety%20of%20human%20tissues"},{"title3":"Expression%20of%20the%20SARS-CoV-2%20cell%20receptor%20gene%20ACE2%20in%20a%20wide%20variety%20of%20human%20tissues"},{"title3":"Expression%20of%20the%20SARS-CoV-2%20cell%20receptor%20gene%20ACE2%20in%20a%20wide%20variety%20of%20human%20tissues"},{"title3":"Expression%20of%20the%20SARS-CoV-2%20cell%20receptor%20gene%20ACE2%20in%20a%20wide%20variety%20of%20human%20tissues"}]}]},{"title1":"Acute myocardial injury is common in patients with COVID-19 and impairs their prognosis","References":[{"title2":"Ace2: from vasopeptidase to SARS virus receptor","References":[{"title3":"Ace2:%20from%20vasopeptidase%20to%20SARS%20virus%20receptor"},{"title3":"Ace2:%20from%20vasopeptidase%20to%20SARS%20virus%20receptor"},{"title3":"Ace2:%20from%20vasopeptidase%20to%20SARS%20virus%20receptor"},{"title3":"Ace2:%20from%20vasopeptidase%20to%20SARS%20virus%20receptor"},{"title3":"Ace2:%20from%20vasopeptidase%20to%20SARS%20virus%20receptor"},{"title3":"Ace2:%20from%20vasopeptidase%20to%20SARS%20virus%20receptor"},{"title3":"Ace2:%20from%20vasopeptidase%20to%20SARS%20virus%20receptor"},{"title3":"Ace2:%20from%20vasopeptidase%20to%20SARS%20virus%20receptor"},{"title3":"Ace2:%20from%20vasopeptidase%20to%20SARS%20virus%20receptor"},{"title3":"Ace2:%20from%20vasopeptidase%20to%20SARS%20virus%20receptor"},{"title3":"Ace2:%20from%20vasopeptidase%20to%20SARS%20virus%20receptor"},{"title3":"Ace2:%20from%20vasopeptidase%20to%20SARS%20virus%20receptor"},{"title3":"Ace2:%20from%20vasopeptidase%20to%20SARS%20virus%20receptor"},{"title3":"Ace2:%20from%20vasopeptidase%20to%20SARS%20virus%20receptor"},{"title3":"Ace2:%20from%20vasopeptidase%20to%20SARS%20virus%20receptor"},{"title3":"Ace2:%20from%20vasopeptidase%20to%20SARS%20virus%20receptor"},{"title3":"Ace2:%20from%20vasopeptidase%20to%20SARS%20virus%20receptor"},{"title3":"Ace2:%20from%20vasopeptidase%20to%20SARS%20virus%20receptor"},{"title3":"Ace2:%20from%20vasopeptidase%20to%20SARS%20virus%20receptor"},{"title3":"Ace2:%20from%20vasopeptidase%20to%20SARS%20virus%20receptor"},{"title3":"Ace2:%20from%20vasopeptidase%20to%20SARS%20virus%20receptor"},{"title3":"Ace2:%20from%20vasopeptidase%20to%20SARS%20virus%20receptor"},{"title3":"Ace2:%20from%20vasopeptidase%20to%20SARS%20virus%20receptor"},{"title3":"Ace2:%20from%20vasopeptidase%20to%20SARS%20virus%20receptor"},{"title3":"Ace2:%20from%20vasopeptidase%20to%20SARS%20virus%20receptor"},{"title3":"Ace2:%20from%20vasopeptidase%20to%20SARS%20virus%20receptor"},{"title3":"Ace2:%20from%20vasopeptidase%20to%20SARS%20virus%20receptor"}]},{"title2":"Cardiovascular complications of severe acute respiratory syndrome","References":[]},{"title2":"Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study","References":[]},{"title2":"COVID-19 and the cardiovascular system","References":[{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"}]},{"title2":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","References":[]},{"title2":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","References":[{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"}]},{"title2":"National Health Commission of the People's Republic of China. Novel Coronavirus-Pneumonia diagnostic and treatment regimens","References":[]},{"title2":"Pneumonia as a cardiovascular disease: Pneumonia-related cardiac damage","References":[]},{"title2":"[Study on the myocardiac injury in patients with severe acute respiratory syndrome]","References":[]},{"title2":"Acute myocarditis associated with novel middle East respiratory syndrome coronavirus","References":[{"title3":"Acute%20myocarditis%20associated%20with%20novel%20middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Acute%20myocarditis%20associated%20with%20novel%20middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Acute%20myocarditis%20associated%20with%20novel%20middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Acute%20myocarditis%20associated%20with%20novel%20middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Acute%20myocarditis%20associated%20with%20novel%20middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Acute%20myocarditis%20associated%20with%20novel%20middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Acute%20myocarditis%20associated%20with%20novel%20middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Acute%20myocarditis%20associated%20with%20novel%20middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Acute%20myocarditis%20associated%20with%20novel%20middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Acute%20myocarditis%20associated%20with%20novel%20middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Acute%20myocarditis%20associated%20with%20novel%20middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Acute%20myocarditis%20associated%20with%20novel%20middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Acute%20myocarditis%20associated%20with%20novel%20middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Acute%20myocarditis%20associated%20with%20novel%20middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Acute%20myocarditis%20associated%20with%20novel%20middle%20East%20respiratory%20syndrome%20coronavirus"}]},{"title2":"Transient cardiac injury during H7N9 infection","References":[]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","References":[]},{"title2":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American thoracic Society and infectious diseases Society of America","References":[{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"},{"title3":"Diagnosis%20and%20treatment%20of%20adults%20with%20community-acquired%20pneumonia.%20An%20official%20clinical%20practice%20guideline%20of%20the%20American%20thoracic%20Society%20and%20infectious%20diseases%20Society%20of%20America"}]},{"title2":"Prevalence of comorbidities in the middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis","References":[]},{"title2":"[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]","References":[{"title3":"[The%20epidemiological%20characteristics%20of%20an%20outbreak%20of%202019%20novel%20coronavirus%20diseases%20(COVID-19)%20in%20China]"}]},{"title2":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","References":[]},{"title2":"Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis","References":[{"title3":"Cardiac%20troponin%20I%20in%20patients%20with%20coronavirus%20disease%202019%20(COVID-19):%20evidence%20from%20a%20meta-analysis"},{"title3":"Cardiac%20troponin%20I%20in%20patients%20with%20coronavirus%20disease%202019%20(COVID-19):%20evidence%20from%20a%20meta-analysis"},{"title3":"Cardiac%20troponin%20I%20in%20patients%20with%20coronavirus%20disease%202019%20(COVID-19):%20evidence%20from%20a%20meta-analysis"},{"title3":"Cardiac%20troponin%20I%20in%20patients%20with%20coronavirus%20disease%202019%20(COVID-19):%20evidence%20from%20a%20meta-analysis"},{"title3":"Cardiac%20troponin%20I%20in%20patients%20with%20coronavirus%20disease%202019%20(COVID-19):%20evidence%20from%20a%20meta-analysis"},{"title3":"Cardiac%20troponin%20I%20in%20patients%20with%20coronavirus%20disease%202019%20(COVID-19):%20evidence%20from%20a%20meta-analysis"},{"title3":"Cardiac%20troponin%20I%20in%20patients%20with%20coronavirus%20disease%202019%20(COVID-19):%20evidence%20from%20a%20meta-analysis"},{"title3":"Cardiac%20troponin%20I%20in%20patients%20with%20coronavirus%20disease%202019%20(COVID-19):%20evidence%20from%20a%20meta-analysis"},{"title3":"Cardiac%20troponin%20I%20in%20patients%20with%20coronavirus%20disease%202019%20(COVID-19):%20evidence%20from%20a%20meta-analysis"},{"title3":"Cardiac%20troponin%20I%20in%20patients%20with%20coronavirus%20disease%202019%20(COVID-19):%20evidence%20from%20a%20meta-analysis"}]}]}]}